Stock Price
11.79
Daily Change
0.58 5.17%
Monthly
-5.15%
Yearly
1.99%
Q1 Forecast
10.78

Clinuvel Pharmaceuticals reported AUD168.8M in Ordinary Share Capital for its fiscal semester ending in June of 2024.





Ordinary Share Capital Change Date
Medical Developments International AUD 115.01M 9.28M Dec/2024
Mesoblast USD 1.28B 127.49M Jun/2025
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Pacific Edge NZD 1.02B 210.22M Dec/2025
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Telix Pharmaceuticals AUD 587.41M 141.14M Jun/2024